Results 131 to 140 of about 49,978 (267)

Correction: Castro et al. Synthesis, Characterization, and Optimization Studies of Polycaprolactone/Polylactic Acid/Titanium Dioxide Nanoparticle/Orange Essential Oil Membranes for Biomedical Applications. <i>Polymers</i> 2023, <i>15</i>, 135. [PDF]

Polymers (Basel)
Castro JI, Astudillo S, Mina Hernandez JH, Saavedra M, Zapata PA, Valencia-Llano CH, Chaur MN, Grande-Tovar CD.   +7 more
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Materiales Magnéticos. Materiales magnéticos duros: hexaferritas

En este Trabajo de Fin de Grado se presentan todos los pasos realizados para alcanzar el objetivo de sintetizar y caracterizar un material magnéticamente duro, la hexaferrita de estroncio. Con este propósito, se realiza una revisión bibliográfica para comprender los conceptos clave sobre el magnetismo en la materia, destacando aquellos más ...
openaire   +1 more source

Influence of the TiO₂ Precursor Phase on the Properties and Photoelectrooxidation Performance of Black TiO₂-Impregnated Electrodes for Acetaminophen Degradation. [PDF]

Molecules
Solarte-Ferro D, Betancourt J, Lara Ramos JA, Millán-Franco M, Diosa JE, Jaramillo-Quintero OA, Gracia-Pinilla M, Machuca-Martínez F, Mosquera-Vargas E.   +8 more
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

MATERIALES

, 2018
openaire   +2 more sources

Mn(III)-O-Ce(IV) as a Surrogate for Highly Reactive Non-Heme Mn(IV)═O Species Supported by Benzimidazole-Based Ligand. [PDF]

Inorg Chem
Gupta S, Sharma P, Velasco L, Hareendran DL, Lomax MJA, Charisiadis A, Jain K, Puthiyadath A, Jackson TA, Mallojjala SC, Moonshiram D, Draksharapu A.   +11 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Is It Possible to Trap 4HNE, the Main Degradation Product of Omega-6? A Theoretical Study of Potential Scavengers. [PDF]

ACS Omega
Ramírez R, Martínez A.
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source